Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2012 | 08-2011 | 08-2010 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,410 | -36,336 | -22,583 | N/A | N/A |
| Depreciation Amortization | 2,059 | 2,075 | 2,420 | N/A | N/A |
| Accounts receivable | 527 | -96 | -745 | N/A | N/A |
| Other Working Capital | -10 | 482 | -260 | N/A | N/A |
| Other Operating Activity | 1,522 | 13,868 | 2,322 | 0 | 0 |
| Operating Cash Flow | $-25,312 | $-20,007 | $-18,846 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,278 | N/A | 12,465 | N/A | N/A |
| PPE Investments | -1,265 | -436 | -2,093 | N/A | N/A |
| Other Investing Activity | 1,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-36,543 | $-436 | $10,372 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 11,425 | N/A | N/A | N/A |
| Debt Repayment | -6,921 | -2,263 | -462 | N/A | N/A |
| Common Stock Issued | 65,696 | 164 | 31 | N/A | N/A |
| Other Financing Activity | 2,500 | 0 | 27,000 | 0 | 0 |
| Financing Cash Flow | $61,275 | $9,326 | $26,569 | $N/A | $N/A |
| Exchange Rate Effect | -262 | -27 | N/A | N/A | N/A |
| Beginning Cash Position | 21,911 | 33,055 | 14,960 | N/A | N/A |
| End Cash Position | 21,069 | 21,911 | 33,055 | N/A | N/A |
| Net Cash Flow | $-842 | $-11,144 | $18,095 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,312 | -20,007 | -18,846 | N/A | N/A |
| Capital Expenditure | -1,265 | -548 | -2,093 | N/A | N/A |
| Free Cash Flow | -26,577 | -20,555 | -20,939 | 0 | 0 |